Home Onxeo: Belinostat Phase I/II Results in Soft Tissue Sarcoma to Be...
 

Keywords :   


Onxeo: Belinostat Phase I/II Results in Soft Tissue Sarcoma to Be...

2015-04-10 00:14:21| Logistics - Topix.net

PARIS & COPENHAGEN, Denmark-- -- Regulatory News: Onxeo S.A. , an innovative company specializing in the development of orphan oncology drugs, today announced that the phase I/II clinical trial of belinostat in combination with doxorubicin in patients with soft tissue sarcoma was accepted for presentation in the Poster Discussion Session at the 2015 Annual Meeting of the American Society of Clinical Oncology , taking place in Chicago, USA from May 29 to June 2, 2015. The PXD101-CLN-14 study was an open -label, multicenter, dose-escalation phase I/II to evaluate the safety and efficacy of the combination of belinostat with doxorubicin in patients with advanced solid tumors and STS .

Tags: to results iii soft

Category:Transportation and Logistics

Latest from this category

All news

24.11Atlantic Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
Transportation and Logistics »
24.11NIKE13FG
24.11adidas
24.11NIKE
24.116
24.11 (UK)CAP
24.11 (
24.11tt011/10 rc
24.11dorachama Lysin 32kg
More »